核酸ベース遺伝子治療の世界市場 2020年

• 英文タイトル：Global Nucleic-Acid Based Gene Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114672 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、核酸ベース遺伝子治療の世界市場を調査対象にし、核酸ベース遺伝子治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（DNA、RNA）、用途別分析（学術・政府研究機関、製薬・バイオテクノロジー企業、受託研究機関、病院・診断センター、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Wave Life Sciences、Celsion、Phylogica、Benitec Biopharma、Copernicus Therapeutics ・企業別売上、市場シェア ・核酸ベース遺伝子治療の地域別市場分析 ・核酸ベース遺伝子治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・核酸ベース遺伝子治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・核酸ベース遺伝子治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・核酸ベース遺伝子治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・核酸ベース遺伝子治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・核酸ベース遺伝子治療の種類別市場規模2015-2020：DNA、RNA ・核酸ベース遺伝子治療の用途別市場規模2015-2020：学術・政府研究機関、製薬・バイオテクノロジー企業、受託研究機関、病院・診断センター、その他 ・核酸ベース遺伝子治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Nucleic-Acid Based Gene Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Nucleic-Acid Based Gene Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Nucleic-Acid Based Gene Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Nucleic-Acid Based Gene Therapeutics market has been segmented into:
DNA
RNA

By Application, Nucleic-Acid Based Gene Therapeutics has been segmented into:
Academic and Government Research Institutes
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Hospitals and Diagnostic Centers
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nucleic-Acid Based Gene Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Nucleic-Acid Based Gene Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nucleic-Acid Based Gene Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Nucleic-Acid Based Gene Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Nucleic-Acid Based Gene Therapeutics Market Share Analysis
Nucleic-Acid Based Gene Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nucleic-Acid Based Gene Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nucleic-Acid Based Gene Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Nucleic-Acid Based Gene Therapeutics are:
Wave Life Sciences
Celsion
Phylogica
Benitec Biopharma
Copernicus Therapeutics

レポート目次

---

1 Nucleic-Acid Based Gene Therapeutics Market Overview
1.1 Product Overview and Scope of Nucleic-Acid Based Gene Therapeutics
1.2 Classification of Nucleic-Acid Based Gene Therapeutics by Type
1.2.1 Global Nucleic-Acid Based Gene Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Type in 2019
1.2.3 DNA
1.2.4 RNA
1.3 Global Nucleic-Acid Based Gene Therapeutics Market by Application
1.3.1 Overview: Global Nucleic-Acid Based Gene Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Academic and Government Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Contract Research Organizations
1.3.5 Hospitals and Diagnostic Centers
1.3.6 Others
1.4 Global Nucleic-Acid Based Gene Therapeutics Market by Regions
1.4.1 Global Nucleic-Acid Based Gene Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nucleic-Acid Based Gene Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nucleic-Acid Based Gene Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Wave Life Sciences
2.1.1 Wave Life Sciences Details
2.1.2 Wave Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Wave Life Sciences SWOT Analysis
2.1.4 Wave Life Sciences Product and Services
2.1.5 Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Celsion
2.2.1 Celsion Details
2.2.2 Celsion Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Celsion SWOT Analysis
2.2.4 Celsion Product and Services
2.2.5 Celsion Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Phylogica
2.3.1 Phylogica Details
2.3.2 Phylogica Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Phylogica SWOT Analysis
2.3.4 Phylogica Product and Services
2.3.5 Phylogica Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Benitec Biopharma
2.4.1 Benitec Biopharma Details
2.4.2 Benitec Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Benitec Biopharma SWOT Analysis
2.4.4 Benitec Biopharma Product and Services
2.4.5 Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Copernicus Therapeutics
2.5.1 Copernicus Therapeutics Details
2.5.2 Copernicus Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Copernicus Therapeutics SWOT Analysis
2.5.4 Copernicus Therapeutics Product and Services
2.5.5 Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nucleic-Acid Based Gene Therapeutics Players Market Share
3.2.2 Top 10 Nucleic-Acid Based Gene Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Market Share by Regions
4.2 North America Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Nucleic-Acid Based Gene Therapeutics Revenue by Countries
5.1 North America Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2015-2020)
5.2 USA Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Nucleic-Acid Based Gene Therapeutics Revenue by Countries
6.1 Europe Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Countries
7.1 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2015-2020)
7.2 China Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Nucleic-Acid Based Gene Therapeutics Revenue by Countries
8.1 South America Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nucleic-Acid Based Gene Therapeutics by Countries
9.1 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nucleic-Acid Based Gene Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Nucleic-Acid Based Gene Therapeutics Market Forecast by Type (2019-2024)
10.3 DNA Revenue Growth Rate (2015-2025)
10.4 RNA Revenue Growth Rate (2015-2025)
11 Global Nucleic-Acid Based Gene Therapeutics Market Segment by Application
11.1 Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Nucleic-Acid Based Gene Therapeutics Market Forecast by Application (2019-2024)
11.3 Academic and Government Research Institutes Revenue Growth (2015-2020)
11.4 Pharmaceutical and Biotechnology Companies Revenue Growth (2015-2020)
11.5 Contract Research Organizations Revenue Growth (2015-2020)
11.6 Hospitals and Diagnostic Centers Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast (2021-2025)
12.1 Global Nucleic-Acid Based Gene Therapeutics Market Size Forecast (2021-2025)
12.2 Global Nucleic-Acid Based Gene Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nucleic-Acid Based Gene Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Wave Life Sciences Corporate Information, Location and Competitors
Table 6. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Major Business
Table 7. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Wave Life Sciences SWOT Analysis
Table 9. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Product and Solutions
Table 10. Wave Life Sciences Nucleic-Acid Based Gene Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Celsion Corporate Information, Location and Competitors
Table 12. Celsion Nucleic-Acid Based Gene Therapeutics Major Business
Table 13. Celsion Nucleic-Acid Based Gene Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Celsion SWOT Analysis
Table 15. Celsion Nucleic-Acid Based Gene Therapeutics Product and Solutions
Table 16. Celsion Nucleic-Acid Based Gene Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Phylogica Corporate Information, Location and Competitors
Table 18. Phylogica Nucleic-Acid Based Gene Therapeutics Major Business
Table 19. Phylogica Nucleic-Acid Based Gene Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Phylogica SWOT Analysis
Table 21. Phylogica Nucleic-Acid Based Gene Therapeutics Product and Solutions
Table 22. Phylogica Nucleic-Acid Based Gene Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Benitec Biopharma Corporate Information, Location and Competitors
Table 24. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Major Business
Table 25. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Benitec Biopharma SWOT Analysis
Table 27. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Product and Solutions
Table 28. Benitec Biopharma Nucleic-Acid Based Gene Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Copernicus Therapeutics Corporate Information, Location and Competitors
Table 30. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Major Business
Table 31. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Copernicus Therapeutics SWOT Analysis
Table 33. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Product and Solutions
Table 34. Copernicus Therapeutics Nucleic-Acid Based Gene Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 36. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Players (2015-2020)
Table 37. Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Regions (2015-2020)
Table 39. North America Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2015-2020)
Table 40. North America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2015-2020)
Table 41. Europe Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Nucleic-Acid Based Gene Therapeutics Revenue by Countries (2015-2020)
Table 44. South America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2015-2020)
Table 47. Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 48. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Type (2015-2020)
Table 49. Global Nucleic-Acid Based Gene Therapeutics Revenue Forecast by Type (2021-2025)
Table 50. Global Nucleic-Acid Based Gene Therapeutics Revenue by Application (2015-2020)
Table 51. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Application (2015-2020)
Table 52. Global Nucleic-Acid Based Gene Therapeutics Revenue Forecast by Application (2021-2025)
Table 53. Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nucleic-Acid Based Gene Therapeutics Picture
Figure 2. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Type in 2019
Figure 3. DNA Picture
Figure 4. RNA Picture
Figure 5. Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Application in 2019
Figure 6. Academic and Government Research Institutes Picture
Figure 7. Pharmaceutical and Biotechnology Companies Picture
Figure 8. Contract Research Organizations Picture
Figure 9. Hospitals and Diagnostic Centers Picture
Figure 10. Others Picture
Figure 11. Global Nucleic-Acid Based Gene Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Nucleic-Acid Based Gene Therapeutics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Nucleic-Acid Based Gene Therapeutics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Regions in 2018
Figure 25. North America Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. South America Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. North America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries in 2019
Figure 32. USA Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries in 2019
Figure 37. Germany Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. UK Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. France Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries in 2019
Figure 44. China Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. India Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. South America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries in 2019
Figure 51. Brazil Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Nucleic-Acid Based Gene Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Type (2015-2020)
Figure 60. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Type in 2019
Figure 61. Global Nucleic-Acid Based Gene Therapeutics Market Share Forecast by Type (2021-2025)
Figure 62. Global DNA Revenue Growth Rate (2015-2020)
Figure 63. Global RNA Revenue Growth Rate (2015-2020)
Figure 64. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Application (2015-2020)
Figure 65. Global Nucleic-Acid Based Gene Therapeutics Revenue Share by Application in 2019
Figure 66. Global Nucleic-Acid Based Gene Therapeutics Market Share Forecast by Application (2021-2025)
Figure 67. Global Academic and Government Research Institutes Revenue Growth Rate (2015-2020)
Figure 68. Global Pharmaceutical and Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 69. Global Contract Research Organizations Revenue Growth Rate (2015-2020)
Figure 70. Global Hospitals and Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Nucleic-Acid Based Gene Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Nucleic-Acid Based Gene Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. Europe Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. South America Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Nucleic-Acid Based Gene Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---